ApoB/ApoA-I Ratio Is Associated With Increased Risk of Bioprosthetic Valve Degeneration
Authors:
- Patrick MathieuPMPatrick Mathieu
- Mario SénéchalMSMario Sénéchal
- Eric LaroseELEric Larose
- Jean DumesnilJDJean Dumesnil
- Jean-Pierre DesprésJDJean-Pierre Després
- Philippe PibarotPPPhilippe Pibarot
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (86666)
This publication has 43 references indexed in Scilit:
- Visceral and Not Subcutaneous Abdominal Adiposity Reduction Drives the Benefits of a 1‐Year Lifestyle Modification ProgramObesity, 2012
- Type 2 Diabetes Mellitus Is Associated With Faster Degeneration of Bioprosthetic ValveCirculation, 2012
- Lipid assessment, metabolic syndrome and coronary heart disease riskEuropean Journal of Clinical Investigation, 2010
- Bisphosphonate Use and Prevalence of Valvular and Vascular Calcification in WomenJACC, 2010
- Lipid‐mediated inflammation and degeneration of bioprosthetic heart valvesEuropean Journal of Clinical Investigation, 2009
- Apolipoprotein-B, Low-Density Lipoprotein Cholesterol, and the Long-Term Risk of Coronary Heart Disease in MenThe American Journal of Cardiology, 2006
- A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic StenosisNew England Journal of Medicine, 2005
- Calcification of Tissue Heart Valve Substitutes: Progress Toward Understanding and PreventionThe Annals of Thoracic Surgery, 2005
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyThe Lancet, 2004
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001